Heart failure with preserved ejection fraction: pathophysiology and emerging therapies.
about
Effect of endurance training on the determinants of peak exercise oxygen consumption in elderly patients with stable compensated heart failure and preserved ejection fraction.New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes.Exercise training in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trial.Understanding results of trials in heart failure with preserved ejection fraction: remembering forgotten lessons and enduring principlesEPA, not DHA, prevents fibrosis in pressure overload-induced heart failure: potential role of free fatty acid receptor 4Effect of endurance exercise training on endothelial function and arterial stiffness in older patients with heart failure and preserved ejection fraction: a randomized, controlled, single-blind trialDiastolic heart failure: the current understanding and approach for management with focus on intensive care unit patients.Diagnosing heart failure with preserved ejection fraction.Effects of renin-angiotensin-aldosterone system inhibitors on mortality, hospitalization, and diastolic function in patients with HFpEF. A meta-analysis of 13 randomized controlled trials.ω3-Polyunsaturated fatty acids for heart failure: Effects of dose on efficacy and novel signaling through free fatty acid receptor 4.Effects of inspiratory muscle training in patients with heart failure with preserved ejection fraction.
P2860
Q30452450-7396E3AE-144F-44A1-A927-9C5CBCBD45A0Q34375466-E2875CA7-9B6F-454B-B45D-1E2D86749F13Q34727504-E6EBE01D-8AA2-40E7-B5E4-0C4C3C0B9008Q34999474-79A2FC83-9158-47AB-9CED-57F06D0599BAQ36307290-ABC00838-FD5B-4976-941D-2FA2101F1BABQ37086510-9A5CC3B9-F51F-4650-86A1-5C8DAEAFA60FQ38025610-D3AC6F0A-BB15-40CE-A1E1-D14C1C1141EAQ38127754-841233BE-5594-4DA1-B16F-C5C9717E33BAQ38566455-8D00B3FA-55DC-43FD-8A63-95E64E12EFE2Q39041784-47D2868D-D9F2-428A-A5A0-DE9F248BC9EFQ48204197-21A2214B-5E9D-4C0D-807B-D96511C85E0D
P2860
Heart failure with preserved ejection fraction: pathophysiology and emerging therapies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Heart failure with preserved ejection fraction: pathophysiology and emerging therapies.
@en
Heart failure with preserved ejection fraction: pathophysiology and emerging therapies.
@nl
type
label
Heart failure with preserved ejection fraction: pathophysiology and emerging therapies.
@en
Heart failure with preserved ejection fraction: pathophysiology and emerging therapies.
@nl
prefLabel
Heart failure with preserved ejection fraction: pathophysiology and emerging therapies.
@en
Heart failure with preserved ejection fraction: pathophysiology and emerging therapies.
@nl
P2860
P1476
Heart failure with preserved ejection fraction: pathophysiology and emerging therapies.
@en
P2093
Aaron M From
Barry A Borlaug
P2860
P356
10.1111/J.1755-5922.2010.00133.X
P577
2010-03-29T00:00:00Z